Skip to Main Content
Alcohol Addiction, Phase I

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

What is the purpose of this trial?

The purpose of this study is to investigate the effects of the psychedelic dimethyltryptamine (DMT), in addition to a short course of psychotherapy, on Alcohol Use Disorder (AUD) and desire to drink alcohol. DMT is a hallucinogenic drug that occurs naturally in certain plants. In this study, we will assess the effects of DMT on alcohol use and brain function, compared to an inactive compound. Participation includes a screening visit, fMRIs, a test day, one-night inpatient stay, and follow up visits. Total estimated compensation is $ 1,400. For more information, please contact study coordinator: Angelina Contreras, abn.lab@yale.edu, 475-441-4190.

Contact Information

For more information about this study, including how to volunteer, contact Angelina Contreras

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    09/22/2025
  • Study HIC
    #2000035937